BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16984992)

  • 1. Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
    Grischuk Y; Rubtsov P; Riepe FG; Grötzinger J; Beljelarskaia S; Prassolov V; Kalintchenko N; Semitcheva T; Peterkova V; Tiulpakov A; Sippell WG; Krone N
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4976-80. PubMed ID: 16984992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency.
    Krone N; Grischuk Y; Müller M; Volk RE; Grötzinger J; Holterhus PM; Sippell WG; Riepe FG
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2682-8. PubMed ID: 16670167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 2005 Jan; 90(1):445-54. PubMed ID: 15483094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Partsch CJ; Vorhoff W; Brämswig J; Sippell WG
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):111-7. PubMed ID: 16636976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.
    Riepe FG; Hiort O; Grötzinger J; Sippell WG; Krone N; Holterhus PM
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2891-5. PubMed ID: 18445671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel missense mutations in CYP21 causing congenital adrenal hyperplasia.
    Robins T; Bellanne-Chantelot C; Barbaro M; Cabrol S; Wedell A; Lajic S
    J Mol Med (Berl); 2007 Mar; 85(3):247-55. PubMed ID: 17119906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia.
    Concolino P; Vendittelli F; Mello E; Minucci A; Carrozza C; Rossodivita A; Giardina B; Zuppi C; Capoluongo E
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):470-6. PubMed ID: 19170707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization and molecular modeling of the mutations in CYP21A2 gene from patients with Congenital Adrenal Hyperplasia.
    Khajuria R; Walia R; Bhansali A; Prasad R
    Biochimie; 2018 Jun; 149():115-121. PubMed ID: 29684512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
    Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
    Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier.
    Tardy V; Menassa R; Sulmont V; Lienhardt-Roussie A; Lecointre C; Brauner R; David M; Morel Y
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1288-300. PubMed ID: 20080860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Brämswig J; Sippell WG
    J Mol Med (Berl); 2005 Jul; 83(7):561-8. PubMed ID: 15830218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene.
    Krone N; Riepe FG; Götze D; Korsch E; Rister M; Commentz J; Partsch CJ; Grötzinger J; Peter M; Sippell WG
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3724-30. PubMed ID: 15755848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP21 mutations in simple virilizing congenital adrenal hyperplasia.
    Lajić S; Robins T; Krone N; Schwarz HP; Wedell A
    J Mol Med (Berl); 2001 Oct; 79(10):581-6. PubMed ID: 11692155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia.
    Robins T; Carlsson J; Sunnerhagen M; Wedell A; Persson B
    Mol Endocrinol; 2006 Nov; 20(11):2946-64. PubMed ID: 16788163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
    Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y
    J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic, metabolic, and molecular genetic characterization of six patients with congenital adrenal hyperplasia caused by novel mutations in the CYP11B1 gene.
    Nguyen HH; Eiden-Plach A; Hannemann F; Malunowicz EM; Hartmann MF; Wudy SA; Bernhardt R
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):126-34. PubMed ID: 26476331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p.H282N and p.Y191H: 2 novel CYP21A2 mutations in Italian congenital adrenal hyperplasia patients.
    Concolino P; Mello E; Patrosso MC; Penco S; Zuppi C; Capoluongo E
    Metabolism; 2012 Apr; 61(4):519-24. PubMed ID: 22014889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of the human steroid 21-hydroxylase gene and its mutant variant C169R in insect cells and functional analysis of expression products].
    Grishchuk IuV; Rubtsov PM; Belzhelarskaia SN
    Mol Biol (Mosk); 2007; 41(1):71-8. PubMed ID: 17380893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital adrenal hyperplasia: the molecular basis of 21-hydroxylase deficiency in H-2(aw18) mice.
    Riepe FG; Tatzel S; Sippell WG; Pleiss J; Krone N
    Endocrinology; 2005 Jun; 146(6):2563-74. PubMed ID: 15731361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.